BC
RMD icon

Brookfield Corp’s ResMed RMD Stock Holding History

Brookfield Corp’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,008
Closed -$6.11M – 723
2022
Q3 		$6.11M Buy
+28,008
New +$6.37M 0.02% 243
2022
Q1 		– Sell
-6,059
Closed -$1.58M – 759
2021
Q4 		$1.58M Sell
6,059
-4,915
-45% -$1.28M 0.01% 369
2021
Q3 		$2.89M Sell
10,974
-261
-2% -$71.4K 0.01% 292
2021
Q2 		$2.77M Buy
+11,235
New +$2.36M 0.01% 304

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Brookfield Corp's RMD Position: Q4 2022 in Review

Brookfield Corp sold out of ResMed (RMD) in Q4 2022, closing a stake of 28,008 shares — an estimated $6.11M sold.

Brookfield Corp first reported a position in RMD in Q2 2021 and held it in 4 quarters. The position peaked at $6.11M in Q3 2022. 730 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Brookfield Corp reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Brookfield Corp sold 28,008 ResMed shares in Q4 2022, an estimated $6.11M.
  • Brookfield Corp first reported a position in ResMed in Q2 2021 and held it in 4 quarters.
  • Brookfield Corp's ResMed position peaked at $6.11M in Q3 2022.
  • 730 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.